Two Types of Hypertension Medications Recalled Due to High Levels of Cancer-Causing Substance Medicine & Technology Oct 19, 2021 The US FDA has released a product recall on two of the hypertension medications of Lupin Pharmaceuticals due to their potential high levels of cancer-causing impurity.
Losartan Potassium Tablets Being Recalled -- Again! Sep 26, 2019 Another recall on Losartan has been announced due to the reported carcinogenic substances contained in the blood pressure medication.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts